全文获取类型
收费全文 | 1538篇 |
免费 | 206篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 55篇 |
妇产科学 | 32篇 |
基础医学 | 303篇 |
口腔科学 | 17篇 |
临床医学 | 197篇 |
内科学 | 263篇 |
皮肤病学 | 16篇 |
神经病学 | 172篇 |
特种医学 | 36篇 |
外科学 | 188篇 |
综合类 | 36篇 |
一般理论 | 23篇 |
预防医学 | 130篇 |
眼科学 | 34篇 |
药学 | 182篇 |
肿瘤学 | 34篇 |
出版年
2023年 | 12篇 |
2022年 | 17篇 |
2021年 | 35篇 |
2020年 | 23篇 |
2019年 | 30篇 |
2018年 | 25篇 |
2017年 | 27篇 |
2016年 | 28篇 |
2015年 | 30篇 |
2014年 | 53篇 |
2013年 | 70篇 |
2012年 | 106篇 |
2011年 | 111篇 |
2010年 | 47篇 |
2009年 | 47篇 |
2008年 | 85篇 |
2007年 | 85篇 |
2006年 | 79篇 |
2005年 | 81篇 |
2004年 | 80篇 |
2003年 | 74篇 |
2002年 | 66篇 |
2001年 | 51篇 |
2000年 | 47篇 |
1999年 | 46篇 |
1998年 | 26篇 |
1997年 | 26篇 |
1996年 | 29篇 |
1995年 | 17篇 |
1994年 | 19篇 |
1993年 | 20篇 |
1992年 | 20篇 |
1991年 | 15篇 |
1990年 | 27篇 |
1989年 | 15篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 9篇 |
1985年 | 15篇 |
1984年 | 7篇 |
1982年 | 7篇 |
1980年 | 10篇 |
1979年 | 10篇 |
1978年 | 6篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1971年 | 7篇 |
1968年 | 5篇 |
1967年 | 6篇 |
排序方式: 共有1744条查询结果,搜索用时 15 毫秒
81.
Multiple sclerosis is the most common, non-traumatic, disabling neurological disease of young adults, affecting an estimated two million people worldwide. At onset multiple sclerosis can be categorised clinically into relapsing remitting MS (RRMS — 85-90% of patients) or primary progressive MS (PPMS). Relapses typically present sub-acutely over hours to days with neurological symptoms persisting for days to weeks before they gradually dissipate. At first full recovery is the norm, later patients accumulate deficits and ultimately most convert to a secondary progressive phase (SPMS), characterised by deficits that increase in the absence of further relapses. The clinical picture reflects the complex interplay of focal inflammation, demyelination and axonal degeneration occurring within the central nervous system.Since the introduction of a genuine disease-modifying drug, interferon-beta1b in 1993, there has been a growing interest from academia and pharmaceutical companies alike in multiple sclerosis therapy. In part this effort has focused on investigating the “window of therapeutic opportunity” within the natural history of the disease: it is becoming increasingly clear that immunotherapies are not useful in the secondary phase of the disease but may offer long-term benefit if given early in the relapsing-remitting phase. In part, attention is being paid to the details of dosing and administration of the various licensed therapies, but there is also a significant research effort to explore new ways to treat the disease. In this review, we first sketch the landscape of novel therapies in multiple sclerosis and then discuss in detail approaches which are likely to emerge over the next few years. 相似文献
82.
Carl A. Anderson Jeffrey C. Barrett Mark Tremelling Rhian Gwilliam Elaine R. Nimmo Charlie W. Lees Catherine Hanson Radhi Ravindrarajah Dhiraj Varma Gregory Lewis Nick Watkins David Strachan Cathryn M. Lewis Jeremy Sanderson Panos Deloukas Christopher G. Mathew Miles Parkes 《Gastroenterology》2009,136(2):523-529
83.
84.
85.
The New Injury Severity Score: Better Prediction of Functional Recovery after Musculoskeletal Injury
Alasdair G. Sutherland MD FRCSEd rew T. Johnston MRCSEd James D. Hutchison PhD 《Value in health》2006,9(1):24-27
OBJECTIVES: Injury Severity Score (ISS) is the most widely used method of assessing severity of injury in blunt trauma. It has been recognized that, by only allowing the score to consider the worst injury for each body system, ISS underestimates the problems of multiple musculoskeletal injuries. The New ISS (NISS) allows the three most severe injuries to be scored, irrespective of region affected, and may give better prediction of functional recovery in these patients. METHODS: A prospective cohort study of 200 patients with musculoskeletal injuries, examining the predictive value of ISS and NISS on functional recovery as measured by patient-derived outcome measures (Short Form-36, Sickness Impact Profile, and Musculoskeletal Function Assessment). RESULTS: NISS was greater than ISS in 34 patients (17%). NISS showed closer correlation with total scores and subscores of the outcomes measures than did ISS (Spearman's rho ranked test, P < 0.05). CONCLUSIONS: NISS, a simple modification from ISS, better predicts functional outcomes in survivors of musculoskeletal trauma, and offers an improvement in the assessment of effectiveness of trauma care delivery. 相似文献
86.
Sogo N Wilkinson IB MacCallum H Khan SQ Strachan FE Newby DE Megson IL Webb DJ 《Clinical pharmacology and therapeutics》2000,68(1):75-81
BACKGROUND: Reduced nitric oxide bioavailability caused by endothelial dysfunction or damage is a contributory factor in the initiation and progression of a number of cardiovascular diseases. Delivery of exogenous nitric oxide is an attractive therapeutic option, but current agents lack selectivity for areas of endothelial damage. We tested the hypothesis that a novel nitric oxide donor drug, N-(S-nitroso-N-acetylpenicillamine)-2-amino-2-deoxy-1,3,4,6-tetra-O-acet yl-P-glucopyranose [RIG200], which has selective effects in endothelium-denuded isolated arteries in vitro, would exert similar effects in dorsal hand veins with experimentally damaged endothelium in vivo. METHODS: Venodilator responses to sodium nitroprusside and RIG200 were compared in two groups of healthy volunteers (age range, 18 to 63 years; n = 7 for each group) in norepinephrine 70% maximum effective concentration (EC70) preconstricted hand veins with use of the Aellig technique. In this doubleblind study, subjects were randomly assigned to receive either sodium nitroprusside or RIG200 (infusions of 0.06 and 6 nmol/min into the hand vein) before and 2 days after 15 minutes of local venous irription with distilled water. Endothelial function was assessed in all subjects on both visits with use of the endothelium-dependent vasodilator acetylcholine (1 nmol/min). RESULTS: Irrigation of hand veins with distilled water abolished endothelium-dependent dilatation in response to acetylcholine in both study groups (n = 14) but did not affect the amplitude or duration of responses to the conventional nitric oxide donor sodium nitroprusside (P = .87; n = 7). However, responses to RIG200 were significantly prolonged during the washout phase (30 minutes) in veins after water irrigation (P = .02; n = 7). CONCLUSION: These studies confirm that RIG200 has prolonged effects in veins with damaged endothelium, a characteristic that might be exploited therapeutically to target nitric oxide delivery to damaged blood vessels. 相似文献
87.
Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis 总被引:3,自引:0,他引:3
下载免费PDF全文
![点击此处可从《Infection and immunity》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Andrews GP Strachan ST Benner GE Sample AK Anderson GW Adamovicz JJ Welkos SL Pullen JK Friedlander AM 《Infection and immunity》1999,67(3):1533-1537
To evaluate the role of Yersinia outer proteins (Yops) in conferring protective immunity against plague, six yop loci from Yersinia pestis were individually amplified by PCR, cloned, and expressed in Escherichia coli. The recombinant proteins were purified and injected into mice. Most Yop-vaccinated animals succumbed to infection with either wild-type encapsulated Y. pestis or a virulent, nonencapsulated isogenic variant. Vaccination with YpkA significantly prolonged mean survival time but did not increase overall survival of mice infected with the nonencapsulated strain. The only significant protection against death was observed in YopD-vaccinated mice challenged with the nonencapsulated strain. 相似文献
88.
89.
90.